1. Home
  2. IQV vs AMX Comparison

IQV vs AMX Comparison

Compare IQV & AMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • AMX
  • Stock Information
  • Founded
  • IQV 1982
  • AMX 2000
  • Country
  • IQV United States
  • AMX Mexico
  • Employees
  • IQV N/A
  • AMX N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • AMX Telecommunications Equipment
  • Sector
  • IQV Health Care
  • AMX Telecommunications
  • Exchange
  • IQV Nasdaq
  • AMX Nasdaq
  • Market Cap
  • IQV 35.7B
  • AMX 42.5B
  • IPO Year
  • IQV 2013
  • AMX 2001
  • Fundamental
  • Price
  • IQV $197.47
  • AMX $13.66
  • Analyst Decision
  • IQV Strong Buy
  • AMX Buy
  • Analyst Count
  • IQV 17
  • AMX 6
  • Target Price
  • IQV $255.88
  • AMX $19.07
  • AVG Volume (30 Days)
  • IQV 1.2M
  • AMX 1.6M
  • Earning Date
  • IQV 02-12-2025
  • AMX 02-11-2025
  • Dividend Yield
  • IQV N/A
  • AMX 3.67%
  • EPS Growth
  • IQV 27.98
  • AMX N/A
  • EPS
  • IQV 7.62
  • AMX 0.03
  • Revenue
  • IQV $15,315,000,000.00
  • AMX $42,537,192,555.00
  • Revenue This Year
  • IQV $3.67
  • AMX $5.39
  • Revenue Next Year
  • IQV $4.53
  • AMX $6.66
  • P/E Ratio
  • IQV $25.89
  • AMX $22.51
  • Revenue Growth
  • IQV 3.10
  • AMX 0.21
  • 52 Week Low
  • IQV $187.62
  • AMX $13.63
  • 52 Week High
  • IQV $261.73
  • AMX $20.31
  • Technical
  • Relative Strength Index (RSI)
  • IQV 45.36
  • AMX 38.22
  • Support Level
  • IQV $194.06
  • AMX $13.63
  • Resistance Level
  • IQV $207.72
  • AMX $14.10
  • Average True Range (ATR)
  • IQV 4.74
  • AMX 0.33
  • MACD
  • IQV 0.12
  • AMX -0.01
  • Stochastic Oscillator
  • IQV 27.90
  • AMX 2.80

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About AMX America Movil S.A.B. de C.V. (each representing the right to receive twenty (20) Series B Shares

America Movil is the largest telecom carrier in Latin America, serving about 290 million wireless customers across the region. It also provides fixed-line phone, internet access, and television services in most of the countries it serves. Mexico is the firm's largest market, providing about 35% of service revenue. Movil dominates the Mexican wireless market with more than 60% customer share and also serves about half of fixed-line internet access customers in the country. Brazil, its second most important market, provides about 20% of service revenue. Movil sold its low-margin wireless resale business in the US to Verizon in 2021 and now owns a 1.4% stake in the US telecom giant. The firm also holds a 60% stake in Telekom Austria.

Share on Social Networks: